These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 17227224)

  • 21. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.
    Lee SH; Rho J; Jeong D; Sul JY; Kim T; Kim N; Kang JS; Miyamoto T; Suda T; Lee SK; Pignolo RJ; Koczon-Jaremko B; Lorenzo J; Choi Y
    Nat Med; 2006 Dec; 12(12):1403-9. PubMed ID: 17128270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis.
    Wada T; Nakashima T; Oliveira-dos-Santos AJ; Gasser J; Hara H; Schett G; Penninger JM
    Nat Med; 2005 Apr; 11(4):394-9. PubMed ID: 15750601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ClC-7 expression levels critically regulate bone turnover, but not gastric acid secretion.
    Supanchart C; Wartosch L; Schlack C; Kühnisch J; Felsenberg D; Fuhrmann JC; de Vernejoul MC; Jentsch TJ; Kornak U
    Bone; 2014 Jan; 58():92-102. PubMed ID: 24103576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity.
    Martin TJ; Ng KW
    J Cell Biochem; 1994 Nov; 56(3):357-66. PubMed ID: 7876329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Stress and cell communication between bone cells].
    Nakashima T
    Clin Calcium; 2013 Nov; 23(11):1595-603. PubMed ID: 24162599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A quantitative histologic study of avian osteopetrotic bone demonstrating normal osteoclast numbers and increased osteoblastic activity.
    Schmidt EV; Crapo JD; Harrelson JM; Smith RE
    Lab Invest; 1981 Feb; 44(2):164-73. PubMed ID: 7464041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification.
    Henriksen K; Sørensen MG; Nielsen RH; Gram J; Schaller S; Dziegiel MH; Everts V; Bollerslev J; Karsdal MA
    J Bone Miner Res; 2006 Jan; 21(1):58-66. PubMed ID: 16355274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoclast biology in the osteopetrotic (op) rat.
    Marks SC; Popoff SN
    Am J Anat; 1989 Dec; 186(4):325-34. PubMed ID: 2589217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoclast biology: lessons from mammalian mutations.
    Marks SC
    Am J Med Genet; 1989 Sep; 34(1):43-54. PubMed ID: 2683780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity.
    Iwasaki R; Ninomiya K; Miyamoto K; Suzuki T; Sato Y; Kawana H; Nakagawa T; Suda T; Miyamoto T
    Biochem Biophys Res Commun; 2008 Dec; 377(3):899-904. PubMed ID: 18952053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic basis for skeletal disease. Molecular advances in sclerosing bone disorders].
    Michigami T
    Clin Calcium; 2010 Aug; 20(8):1196-202. PubMed ID: 20675930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of bone formation and resorption: biological and clinical perspective.
    Rodan GA
    J Cell Biochem Suppl; 1998; 30-31():55-61. PubMed ID: 9893256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone cell interactions and regulation by inflammatory mediators.
    Oates TW; Cochran DL
    Curr Opin Periodontol; 1996; 3():34-44. PubMed ID: 8624568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cellular basis of bone resorption.
    Chambers TJ
    Clin Orthop Relat Res; 1980 Sep; (151):283-93. PubMed ID: 7418318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteopetrosis--multiple pathways for the interception of osteoclast function.
    Marks SC
    Appl Pathol; 1987; 5(3):172-83. PubMed ID: 3304355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
    Väänänen K
    Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage colony-stimulating factor restores bone resorption in op/op bone in vitro in conjunction with parathyroid hormone or 1,25-dihydroxyvitamin D3.
    Morohashi T; Corboz VA; Fleisch H; Cecchini MG; Felix R
    J Bone Miner Res; 1994 Mar; 9(3):401-7. PubMed ID: 8191935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoclast culture and resorption assays.
    Bradley EW; Oursler MJ
    Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphological evidence of reduced bone resorption in osteopetrotic (op) mice.
    Marks SC
    Am J Anat; 1982 Feb; 163(2):157-67. PubMed ID: 7072615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.